Strain-specific seroepidemiology and reinfection of cytomegalovirus

Microbes and Infection

Volumn 10, Issue 12-13, 2008, Pages 1363-1369

  Ishibashi, Kei ^a   Tokumoto, Tadahiko ^b   Shirakawa, Hiroki ^b   Hashimoto, Koichi ^a   Kushida, Nobuhiro ^a   Yanagida, Tomohiko ^a   Shishido, Keiichi ^a   Aikawa, Ken ^a   Yamaguchi, Osamu ^a   Toma, Hiroshi ^b   Tanabe, Kazunari ^b   Suzutani, Tatsuo ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Antibody; Cytomegalovirus; Glycoprotein H; Reinfection; Seroepidemiology

Indexed keywords

GLYCOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; VIRUS STRAIN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SEROEPIDEMIOLOGIC STUDIES; SPECIES SPECIFICITY; VIRAL ENVELOPE PROTEINS; YOUNG ADULT;

CYTOMEGALOVIRUS;

EID: 54849418867     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.08.001     Document Type: Article

References (27)

1. Ljungman P., Griffiths P., and Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin. Infect. Dis. 34 (2002) 1094-1097
2. Fryd D.S., Peterson P.K., Ferguson R.M., Simmons R.L., Balfour Jr. H.H., and Najarian J.S. Cytomegalovirus as a risk factor in renal transplantation. Transplantation 30 (1980) 436-439
3. Singh N. Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy. Rev. Med. Virol. 16 (2006) 281-287
4. Snydman D.R. The case for cytomegalovirus prophylaxis in solid organ transplantation. Rev. Med. Virol. 16 (2006) 289-295
5. Fowler K.B., Dahle A.J., Boppana S.B., and Pass R.F. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?. J. Pediatr. 135 (1999) 60-64
6. Ogawa H., Suzutani T., Baba Y., Koyano S., Nozawa N., Ishibashi K., Fujieda K., Inoue N., and Omori K. Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J. Infect. Dis. 195 (2007) 782-788
7. Kenneson A., and Cannon M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 17 (2007) 253-276
8. Dollard S.C., Grosse S.D., and Ross D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 17 (2007) 355-363
9. Boppana S.B., Rivera L.B., Fowler K.B., Mach M., and Britt W.J. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 344 (2001) 1366-1371
10. Ishibashi K., Tokumoto T., Tanabe K., Shirakawa H., Hashimoto K., Kushida N., Yanagida T., Inoue N., Yamaguchi O., Toma H., and Suzutani T. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes. Clin. Infect. Dis. 45 (2007) 60-67
11. Klein M., Schoppel K., Amvrossiadis N., and Mach M. Strain-specific neutralization of human cytomegalovirus isolates by human sera. J. Virol. 73 (1999) 878-886
12. Urban M., Klein M., Britt W.J., Hassfurther E., and Mach M. Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response. J. Gen. Virol. 77 Pt 7 (1996) 1537-1547
13. Meyer H., Sundqvist V.A., Pereira L., and Mach M. Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies. J. Gen. Virol. 73 Pt 9 (1992) 2375-2383
14. Ohlin M., Sundqvist V.A., Mach M., Wahren B., and Borrebaeck C.A. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. J. Virol. 67 (1993) 703-710
15. Schoppel K., Hassfurther E., Britt W., Ohlin M., Borrebaeck C.A., and Mach M. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures. Virology 216 (1996) 133-145
16. Britt W.J., and Mach M. Human cytomegalovirus glycoproteins. Intervirology 39 (1996) 401-412
17. Kniess N., Mach M., Fay J., and Britt W.J. Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus. J. Virol. 65 (1991) 138-146
18. Balachandran N., Oba D.E., and Hutt-Fletcher L.M. Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus. J. Virol. 61 (1987) 1125-1135
19. Chou S., and Marousek G.I. Homology of the envelope glycoprotein B of human herpesvirus-6 and cytomegalovirus. Virology 191 (1992) 523-528
20. Nicholas J. Determination and analysis of the complete nucleotide sequence of human herpesvirus. J. Virol. 70 (1996) 5975-5989
21. Rothe M., Pepperl-Klindworth S., Lang D., Vornhagen R., Hinderer W., Weise K., Sonneborn H.H., and Plachter B. An antigen fragment encompassing the AD2 domains of glycoprotein B from two different strains is sufficient for differentiation of primary vs. recurrent human cytomegalovirus infection by ELISA. J. Med. Virol. 65 (2001) 719-729
22. Tanabe K., Tokumoto T., Ishikawa N., Koyama I., Takahashi K., Fuchinoue S., Kawai T., Koga S., Yagisawa T., Toma H., Ota K., and Nakajima H. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 64 (1997) 1721-1725
23. Eggers M., Radsak K., Enders G., and Reschke M. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy. J. Med. Virol. 63 (2001) 135-142
24. Pignatelli S., Dal Monte P., Rossini G., and Landini M.P. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev. Med. Virol. 14 (2004) 383-410
25. Chou S. Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. J. Infect. Dis. 166 (1992) 604-607
26. Rasmussen L., Geissler A., and Winters M. Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J. Infect. Dis. 187 (2003) 809-819
27. Shimamura M., Mach M., and Britt W.J. Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response. J. Virol. 80 (2006) 4591-4600